Applied Therapeutics, Inc. (APLT)
NASDAQ: APLT · Real-Time Price · USD
0.4303
-0.0123 (-2.78%)
At close: Jul 30, 2025, 4:00 PM
0.4302
-0.0001 (-0.02%)
After-hours: Jul 30, 2025, 4:11 PM EDT
Applied Therapeutics Revenue
Applied Therapeutics had revenue of $265.00K in the twelve months ending March 31, 2025, down -155.56% year-over-year. In the year 2024, Applied Therapeutics had annual revenue of $455.00K, down -95.45%.
Revenue (ttm)
$265.00K
Revenue Growth
-155.56%
P/S Ratio
241.20
Revenue / Employee
$7,571
Employees
35
Market Cap
60.93M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 455.00K | -9.54M | -95.45% |
Dec 31, 2023 | 9.99M | - | - |
Dec 31, 2022 | - | - | - |
Dec 31, 2021 | - | - | - |
Dec 31, 2020 | - | - | - |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 57.37B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
APLT News
- 6 weeks ago - Applied Therapeutics Announces Key Leadership Appointments - GlobeNewsWire
- 2 months ago - Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting - GlobeNewsWire
- 2 months ago - Applied Therapeutics Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - Applied Therapeutics Announces Acceptance of Late-Breaking Abstract for Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting - GlobeNewsWire
- 4 months ago - Applied Therapeutics Files Form 12b-25 with the Securities and Exchange Commission - GlobeNewsWire
- 4 months ago - Applied Therapeutics Appoints Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer - GlobeNewsWire
- 5 months ago - INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Applied Therapeutics - Accesswire
- 5 months ago - APLT COURT NEWS: Applied Therapeutics has been Sued for Securities Fraud; Contact BFA Law by February 18 if You Lost Money (NASDAQ:APLT) - GlobeNewsWire